Denied Speech Therapy Appeals: Reviewer Outcomes

Evaluation and treatment of speech, language, voice and swallowing disorders, billed by the treating clinician and reviewed against visit limits and progress criteria.

What the independent reviewers decided

68%

overturned by the independent reviewer

111

of 164 decisions in the corpus

Source

California DMHC independent medical review determinations, 2017-2026. Public record.

Read this as a base rate, not as your odds

These are decisions about other patients, in one state, that had already been through the plan's own internal appeal and were then sent to an outside reviewer. That population is self-selected toward disputes worth pursuing, so the rate says what happened to cases like this at that stage — not what will happen to a specific claim. It is not medical or legal advice.

Why plans deny speech therapy

The plan's visit allowance for the benefit year has been reached.
Progress is characterised as a plateau, and the policy covers only therapy expected to produce further gain.
The impairment is classed as developmental where the policy excludes developmental services.
The plan of care does not state measurable goals in the terms the policy expects.

What actually carried the cases that won

Functional impact carried 66% of the overturned decisions, with guideline support close behind at 57%. The pattern is a record that describes consequence rather than activity: what the patient cannot do at school, at work or at the table, and what changed while therapy was running. Plateau denials fell where the file showed a measured gain against a stated baseline. Peer-reviewed literature was the authority reviewers relied on most.

What the record showed	Share of overturned decisions
The functional impact on the patient was documented	66%
A published guideline supported the request	57%
The condition was documented as chronic or long-standing	23%
The severity or urgency was documented	22%
The diagnosis was confirmed	21%
Conservative treatment was documented as failed	7%
Objective findings were documented	4%
Prior treatment was documented	2%

Shares are of the overturned decisions and do not sum to 100% — a single decision often rested on more than one, and some rested on none of these.

What the reviewers cited

Peer-reviewed literature — in 36% of the overturned decisions
Specialty-society criteria — in 10% of the overturned decisions
Clinical guidelines — in 8% of the overturned decisions
Standard of care — in 4% of the overturned decisions

speech therapy denials — frequently asked

Is denied speech therapy worth appealing?

Two thirds of these disputes went the practice's way: California independent reviewers reversed 111 of the 164 they decided. Visit-limit and plateau denials in this corpus did not hold up well once a neutral reviewer read the functional record.

How is a plateau denial answered?

With a measurement. The reversals showed a documented gain against a stated baseline over the period in question — intelligibility, swallow safety, functional communication — rather than a clinician's assessment that progress continues.

Does a developmental exclusion end the argument?

Not necessarily. Where the impairment follows an illness or injury rather than a developmental course, the record has to establish that distinction explicitly, because the exclusion is applied from the diagnosis on the claim.

Source

California Department of Managed Health Care — independent medical review determinations

Denial reasons and criteria are described in plain language for reference and vary by plan and policy. This page reports what independent reviewers decided in a public California dataset; it is general information, not medical, legal, or coverage advice.

When the appeal has to be written, and cited

Upload the denied EOB and Merits returns a complete, citation-verified appeal letter — the clinical argument, the payer's own coverage criteria, and your federal appeal rights — in about a minute.

Appeal a denial →